Pilot drugs are the original providers of new drug research and development and drug big data services. By establishing a DNA-encoded compound library, users can quickly screen the whole library and get emerging compounds with drug-like properties, which shortens the screening time from several months to several days, thus reducing the research and development cost. In addition, the company is also involved in the research and development of new drugs in the field of diseases that do not meet clinical needs, and the drug field is concentrated in the field of major disease metabolism and ophthalmic diseases.
More peer analysis, the company knows and understands.